G. Steven Burrill

Welcome from the CEO

Flash required to view this video. Download the latest version here

 G. Steven Burrill 
TJOLS available online
 

Podcast

Hear 
G. Steven Burrill's vision of healthcare in the year 2020 in a special podcast from The Journal of Life Sciences.
Hear the podcast 
Sign up to receive email notifications about our upcoming events and news.


 
Burrill is the creator, sponsor and facilitator of over a dozen leading industry conferences worldwide and publishes a wide range of bio-intelligence reports including: its annual State of the Industry, The Personalized Medicine Report, The Stem Cell Report, and periodic newsletters covering Canada, China, Europe, India, Japan and Partnering/M&A. Burrill also publishesThe Journal of Life Sciences a bimonthly magazine available at www.tjols.com/currentissue.

Annual Biotechnology Industry Reports

Biotech 2008: A 20/20 Vision To 2020 (Print) Biotech 2008 – Life Sciences: A 20/20 Vision to 2020 is Burrill & Company's 22nd annual report on the state of the biotech industry, highlighting the critical developments in 2007. This edition has a special focus on the future and looks forward just over a decade at the projected environment for the industry in the year 2020…and develops the pathway that will lead us there. › Learn More


Add to cart$430.00

Biotech 2008: A 20/20 Vision To 2020 (Online) This edition has a special focus on the future and looks forward just over a decade at the projected environment for the industry in the year 2020…and develops the pathway that will lead us there.

*Single User Access only. For Multiple User rates contact pwinter@b-c.com › Learn More


Add to cart$295.00

 

State-of-the-Industry at BIO International Convention 2008 The biotechnology industry's leading expert and visionary G. Steven Burrill, CEO of Burrill & Company spoke about the future of the biotechnology industry at BIO 2008. Mr. Burrill reflected on the events that occurred during the 13 months that have elapsed since BIO 2007 and presented insightful data on the financial performance of the biotechnology industry. Building on these statistics he provided his predictions for the rest of the year and his visions for the industry in 2020. Mr. Burrill's presentation (184 slides) are available free-of-charge with the purchase of Biotech 2008, or may be ordered by clicking the checkout button below. › Learn More


Add to cart$250.00

BIOTECH 2007 (Print) The 21st Edition of BIOTECH 2007 focuses on the emergence of biotechnology as a global industry. This publication provides an overview of the latest developments and trends in biotech around the world along with detailed analysis on the progress and prospects for each nation reviewed. › Learn More


Add to cart$235.00

 

BUNDLE: Biotech 2008: A 20/20 Vision To 2020 (Print and Online)

 In an industry where change is a constant, Biotech 2008 is the industry’s “roadmap” and a must read for all those interested in the revolution taking place in the life sciences world…changing the way we heal the world, feed the world, and fuel the world.

*Single User Access only. For Multiple User rates contact pwinter@b-c.com

 

› Learn More
Includes
Biotech 2008: A 20/20 Vision To 2020 (Print)
Biotech 2008: A 20/20 Vision To 2020 (Online)

Add to cart$680.00

   See all subcategory
 

Burrill Biotechnology Report

The Burrill Biotechnology Report: Annual Subscription The Burrill Biotechnology Report has the detailed market intelligence you need each month to obtain an accurate overview of all the latest global developments and trends. › Learn More


Add to cart$1,999.00

The Burrill Biotechnology Report August/September 2008: Single Issue The Burrill Biotechnology Report has the detailed market intelligence you need each month to obtain an accurate overview of all the latest global developments and trends in the life sciences industry. › Learn More


Add to cart$299.00

 

The Burrill Biotechnology Report Excerpt August/September 2008: CEO Interview, Free with Registration Every issue, BBR will be publishing an “in depth” interview with a Biotech company CEO. We are extremely pleased to kick off this feature with George Scangos, CEO of Exelixis, who paints a very sobering picture of today’s turbulent economic climate and its impact on the biotech industry: With investors in risk-avoidance mode and demanding later and later data on lead products before they invest, where will the cash come from to conduct later trials in order to satisfy these demands? › Learn More


   See all subcategory
 

Canadian Biotechnology

Burrill Canadian Biotech Weekly News The Burrill Canadian Biotech News is a premier weekly biotechnology publication, which has been reporting on the Canadian biotech industry for over 17 years. › Learn More


Add to cart$775.00

  See all subcategory
 

BioIntelligence Reports

The Stem Cell Report and Stem Cell Summit Webcast (DVD Price) The Stem Cell Report (Published October 2007, 200 pages PDF on CD-Rom) and Stem Cell Summit Webcast › Learn More


Add to cart$495.00

The Personalized Medicine Intelligence Report 2007 Personalized Medicine Report, November 2007 › Learn More


Add to cart$95.00

   See all subcategory
    

Resources

State of the Life Sciences Industry State of the Life Sciences Industry G. Steven Burrill › Learn More


The Healthcare World in 2020 The Healthcare World in 2020 (Rx/Dx/Vx/Delivery/Providers/Payors) - What will the healthcare world look like? › Learn More


 

Technologies and Systems Biology in 2020 Technologies & Systems Biology in 2020 - Where will we really be technologically? George Poste, Director, Biodesign Institute, Arizona State University › Learn More


Will we live in a world dominated by “alternative fuels” clean tech? Biofuels/ Industrial Biotech – Will we live in a world dominated by “alternative fuels” clean tech? › Learn More


   See all subcategory